Prevalence of Acid-Reducing Agents (ARA) in Cancer Populations and ARA Drug–Drug Interaction Potential for Molecular Targeted Agents in Clinical Development

JOURNAL ARTICLE published 4 November 2013 in Molecular Pharmaceutics

Authors: Gillian S. Smelick | Timothy P. Heffron | Laura Chu | Brian Dean | David A. West | Scott L. DuVall | Bert L. Lum | Nageshwar Budha | Scott N. Holden | Leslie Z. Benet | Adam Frymoyer | Mark J. Dresser | Joseph A. Ware